Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vienna PEP Study
2004-004209-98Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Mar 2005
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in kidney transplant comparing Tacrolimus conversion arm with Cyclosporine maintenance arm (2 arms). Primary endpoints: Change in endothelial progenitor cell count and Change in cystatin C. Started Mar 2005; status: completed.
02
Drugs
tacrolimuscyclosporine
03
Conditions
kidney transplant
Beyond the preview
Go deeper on 2004-004209-98.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004209-98.